Login / Signup

Enhancing inclusivity in clinical trials: Model-informed drug development for pregnant individuals in the era of personalized medicine.

André DallmannPeter L BonateJanelle M BurnhamBlessy A GeorgeLynne YaoJane Knöchel
Published in: CPT: pharmacometrics & systems pharmacology (2024)
Keyphrases
  • clinical trial
  • pregnant women
  • phase ii
  • study protocol
  • open label
  • double blind